Eyepoint Pharmaceuticals Inc (EYPT) — Cash Flow Quality Index

Latest as of September 2014: -0.19x

Eyepoint Pharmaceuticals Inc (EYPT) has a Cash Flow Quality Index of -0.19x as of September 2014. Operating cash flow of $-3.99 Million is below net income of $20.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Eyepoint Pharmaceuticals Inc total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.19x
Operating CF / Net Income

Operating Cash Flow

$-3.99 Million
USD

Net Income

$20.57 Million
USD

Data as of

Sep 2014
Most recent filing

Eyepoint Pharmaceuticals Inc Cash Flow Quality Index (2010–2015)

Historical Cash Flow Quality Index for Eyepoint Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Eyepoint Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Eyepoint Pharmaceuticals Inc (2010–2015)

Year-by-year earnings quality comparison for Eyepoint Pharmaceuticals Inc. For live market cap and the full company financial profile, see Eyepoint Pharmaceuticals Inc stock valuation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2015 1.62x $10.30 Million $6.35 Million ▲ +43.5%
2010 1.13x $9.90 Million $8.75 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.